produces a sustainable supply of semi-synthetic paclitaxel API for clinical research and commercial sales at competitive prices for the global market. NPI additionally produces docetaxel.
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2024 All Rights Reserved
© 2022 All Rights Reserved